Extended-interval dosing of natalizumab in NOVA - Authors' reply.
Saved in:
| Title: | Extended-interval dosing of natalizumab in NOVA - Authors' reply. |
|---|---|
| Authors: | Foley JF; Rocky Mountain Multiple Sclerosis Clinic, Salt Lake City, UT 84103, USA. Electronic address: jfoley@rmmsc.com., Campbell N; Biogen, Cambridge, MA, USA., Kong G; Biogen, Cambridge, MA, USA. |
| Source: | The Lancet. Neurology [Lancet Neurol] 2023 Mar; Vol. 22 (3), pp. 200-201. |
| Publication Type: | Letter; Comment |
| Journal Info: | Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 101139309 Publication Model: Print Cited Medium: Internet ISSN: 1474-4465 (Electronic) Linking ISSN: 14744422 NLM ISO Abbreviation: Lancet Neurol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1474-4465 |
|---|---|
| DOI: | 10.1016/S1474-4422(23)00034-0 |
